RightFit
RecruitingNot applicable

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 64 Years
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests an early version of TEAMWork, a mobile app meant to help people with breast cancer keep their jobs during and after treatment. It gives tips for talking with employers and doctors about cancer and work. Different parts of the study include people starting or getting treatment, people who finished treatment, and people testing how easy the app is to use.

The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • For patient app testing: be 18 or older and have a history of cancer. Men and women may join.
  • For community app testing: be 18 or older. Men and women may join.
  • For both app-testing groups and the discussion or interview groups: be able to understand and agree to join in English or Spanish. Own a smartphone and be able to read and use it.
  • For discussions and interviews: be a woman age 18–64 who finished chemotherapy, or cancer drug treatment, for stage I–III breast cancer.
  • For discussions and interviews: have had paid full-time or part-time work in the 3 months before diagnosis or when agreeing to join MSK study #10-071.
  • For group 2: have had Emergency Medicaid when diagnosed or at any time during breast cancer treatment.
  • For the randomized trial: be a woman age 18–64 with stage I–III breast cancer who plans to get or is getting chemotherapy.
  • For the randomized trial: work full time or part time, prefer English or Spanish, and have access to a smartphone or tablet you can read and use. People on disability or medical leave may join; the study leader may allow other work situations.

Who can't join

  • For the randomized trial: stage 0 breast cancer, also called DCIS.
  • For the randomized trial: stage IV breast cancer, meaning cancer that has spread to distant parts of the body.
  • For the randomized trial: breast cancer that has come back and spread to distant parts of the body.
  • For the randomized trial: you or a family member is taking part in MSK IHCD studies about how social and living conditions affect health.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Patient Usability Testing Inclusion Criteria: * History of a cancer diagnosis * At least 18 years of age * Male or Female * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) Community Usability Testing Inclusion Criteria: * At least 18 years of age * Male or Female * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) Focus Group and Interview Inclusion Criteria: * Completed chemotherapy treatment for stage I-III breast cancer. * Age 18 to 64 (inclusive) * Female * Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder) * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) For Cohort 2: * Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer RCT Inclusion Criteria: * Localized invasive breast cancer (not stage 0 or stage IV) per EMR or breast cancer (not stage 0 or stage IV) per self-report for community participants * If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III * Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy per EMR or planning to undergo or undergo chemotherapy per self-report for community participants * Age 18 to 64 (inclusive) * Female * Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible) * Language preference as English or Spanish * Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android) * Has access to a smartphone or tablet (e.g. iPad, iPhone or Android) Exclusion Criteria: RCT Exclusion Criteria: * Stage 0 breast cancer (DCIS only) * Stage IV (metastatic) breast cancer * Recurrence with metastases of breast cancer * Participants or family members who are participating in MSK IHCD studies related to social determinants of health

Study sites (9)

NJ

NY